The Centers for Disease Control and Prevention has announced that a potentially deadly and drug-resistant fungus is quickly spreading through U.S. health care facilities.
Candida auris is not considered a threat to healthy people whose immune systems can fight it off. However, it can be dangerous or even deadly for people who are already sick, use invasive medical devices or have long or frequent stays at medical facilities.
Read the CDC's public statement below.
Candida auris (C. auris), an emerging fungus considered an urgent antimicrobial resistance (AR) threat, spread at an alarming rate in U.S. healthcare facilities in 2020-2021, according to data from the Centers for Disease Control and Prevention (CDC) published in the Annals of Internal Medicine. Equally concerning was a tripling in 2021 of the number of cases that were resistant to echinocandins, the antifungal medicine most recommended for treatment of C. auris infections.
In general, C. auris is not a threat to healthy people. People who are very sick, have invasive medical devices, or have long or frequent stays in healthcare facilities are at increased risk for acquiring C. auris. CDC has deemed C. auris as an urgent AR threat, because it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates.
“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said CDC epidemiologist Dr. Meghan Lyman, lead author of the paper.
As further explained in the article, C. auris has spread in the United States since it was first reported in 2016, with a total of 3,270 clinical cases (in which infection is present) and 7,413 screening cases (in which the fungus is detected but not causing infection) reported through December 31, 2021. Clinical cases have increased each year since 2016, with the most rapid rise occurring during 2020-2021. CDC has continued to see an increase in case counts for 2022.
During 2019-2021, 17 states identified their first C. auris case ever. Nationwide, clinical cases rose from 476 in 2019 to 1,471 in 2021. Screening cases tripled from 2020 to 2021, for a total of 4,041. Screening is important to prevent spread by identifying patients carrying the fungus so that infection prevention controls can be used.
C. auris case counts have increased for many reasons, including poor general infection prevention and control (IPC) practices in healthcare facilities. Case counts may also have increased because of enhanced efforts to detect cases, including increased colonization screening, a test to see if someone has the fungus somewhere on their body but does not have an infection or symptoms of infection.
The timing of this increase and findings from public health investigations suggest C. auris spread may have worsened due to strain on healthcare and public health systems during the COVID-19 pandemic.
The CDC’s Antimicrobial Resistance Laboratory Network, which provides nationwide lab capacity to rapidly detect antimicrobial resistance and inform local responses to prevent spread and protect people, provided some of the data for this report.
CDC worked to significantly strengthen laboratory capacity, including in state, territorial, and local health departments, through supplemental funding supported by the American Rescue Plan Act. These efforts include increasing susceptibility testing capacity for C. auris from seven Regional Labs to more than 26 labs nationwide.
CDC continues to work with state, local, and territorial health departments and other partners to address this emerging threat to public health.
Review more information on C. auris, the Antimicrobial Resistance Threats Report that identified C. auris as an urgent threat in the United States, or the WHO fungal priority pathogen list that identifies C. auris as a priority globally.
Visit The Sharyl Attkisson Store today
Unique gifts for independent thinkers
Proceeds benefit independent journalism
Bill Andrews says
This Article I doubt it ??? Try creating a New Ozone compressed Gas sprayer with a high intensity Ultra-Violet light on end Sprayer ---> Spraying down everything, with Steven Colbare running it with a raised Eyebrow and toothpick on side of mouth with a mousey smirk and Dr. Fauci on the ground laughing ??? " The More you know !
Bill Andrews says
My earlier post on Space/ light/ Matter= LOL, Steven Colbare, you know what happens to Micro- Growth life when you send out Ozone gases being charged with 10_15~ Hz to > 10_16 Hz Frequency Ultra-Violet Hz charging Ozone Gas Molecules = Not much in Reproductive life after that, Here on earth or in the Vacuum of space ! ' Ha ! Ha! Ha!
Bill Andrews says
Sharyl this Article other important Rainy day Tip.. I think if you can save some young lady and gentlemen's Eye sight you should come forward and offer good advice ? You know those Artificial Tears products that had contamination bacteria ? I wonder if the people manufacturing these products in there manufacturing process wouldn't better profit Before adding solution to inside of bottles to be shipped out, First Flash the Solution and inside of plastic bottles with t'= 10_15 ~Ultra violet Hz light Thus ( E,E ) Matrix De-Contamination New added processing ? = Smarty Pants dance ?